2018 was a remarkable year for the Canadian Cancer Society (CCS). We continued to innovate and take bold steps to ensure we are a strong organization, and that we are well positioned to improve the cancer experience by helping people live longer and enhancing their quality of life.
The financials for 2018/19 reflect our ongoing commitment to maximizing the impact of donor dollars, including lowering the amount we spend on fundraising and increasing the portion of our spending that goes toward our mission.
We look to the year ahead with optimism and determined focus, knowing we are moving closer to realizing our vision of a world where no Canadian fears cancer. With the help of our supporters, we are a force-for-life in the face of cancer.
Read our national financial statements:
Information about our T3010
Charities are legally required to file a Registered Charity Information Return (T3010) to the Canada Revenue Agency (CRA). It discloses financial information including the CCS’s programs, fundraising activities and executive compensation. As of February 1, 2015, the CCS’s internal provincial divisions and the national office have amalgamated their business numbers under the Canada Revenue Agency. As a result, CRA no longer provides access to the regions’ separate T3010. Read our most recent T3010.
Our Impact Reports
Read our annual reports and find out how we’re making a meaningful difference to Canadians.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.